Chemistry Reference
In-Depth Information
Singh SB. Nodulisporic Acid A, a novel and potent insecticide from a nodulisporium
sp. Isolation, structure determination, and chemical transformations. J. Am. Chem.
Soc. 1997;119:8809-8816.
153. Meinke PT, Smith MM, Shoop WL. Nodulisporic acid: its chemistry and biology.
Curr. Top. Med. Chem. 2002;2:655-674.
154. Chang RS, Lotti VJ, Monaghan RL, Birnbaum J, Stapley EO, Goetz MA, Albers-
Schonberg G, Patchett AA, Liesch JM, Hensens OD, et al. A potent nonpeptide
cholecystokinin antagonist selective for peripheral tissues isolated from Aspergillus
alliaceus. Science 1985;230:177-179.
155. Evans BE, Bock MG, Rittle KE, DiPardo RM, Whitter WL, Veber DF, Anderson PS,
Freidinger RM. Design of potent, orally effective, nonpeptidal antagonists of the pep-
tide hormone cholecystokinin. Proc. Natl. Acad. Sci. U.S.A. 1986;83:4918-4922.
156. Bock MG, DiPardo RM, Evans BE, Rittle KE, Whitter WL, Veber DE, Anderson PS,
Freidinger RM. Benzodiazepine gastrin and brain cholecystokinin receptor ligands:
L-365,260. J. Med. Chem. 1989;32:13-16.
157. Darkin-Rattray SJ, Gurnett AM, Myers RW, Dulski PM, Crumley TM, Allocco
JJ, Cannova C, Meinke PT, Colletti SL, Bednarek MA, Singh SB, Goetz MA,
Dombrowski AW, Polishook JD, Schmatz DM. Apicidin: a novel antiprotozoal agent
that inhibits parasite histone deacetylase. Proc. Natl. Acad. Sci. U.S.A. 1996;93:
13143-13147.
158. Singh SB, Zink DL, Liesch JM, Mosley RT, Dombrowski AW, Bills GF, Darkin-
Rattray SJ, Schmatz DM, Goetz MA. Structure and chemistry of apicidins, a class
of novel cyclic tetrapeptides without a terminal alpha-keto epoxide as inhibitors
of histone deacetylase with potent antiprotozoal activities. J. Org. Chem. 2002;67:
815-825.
159. Han JW, Ahn SH, Park SH, Wang SY, Bae GU, Seo DW, Kwon HK, Hong S, Lee
HY, Lee YW, Lee HW. Apicidin, a histone deacetylase inhibitor, inhibits prolif-
eration of tumor cells via induction of p21WAF1/Cip1 and gelsolin. Cancer Res.
2000;60:6068-6074.
160. Kim MS, Son MW, Kim WB, In Park Y, Moon A. Apicidin, an inhibitor
of histone deacetylase, prevents H-ras-induced invasive phenotype. Cancer Lett.
2000;157:23-30.
161. Jones P, Altamura S, Chakravarty PK, Cecchetti O, De Francesco R, Gallinari P,
Ingenito R, Meinke PT, Petrocchi A, Rowley M, Scarpelli R, Serafini S, Steinkuhler
C. A series of novel, potent, and selective histone deacetylase inhibitors. Bioorg.
Med. Chem. Lett. 2006;16:5948-5952.
162. Remiszewski SW. Recent advances in the discovery of small molecule histone
deacetylase inhibitors. Curr. Opin. Drug Discov. Devel. 2002;5:487-499.
163. Singh SB, Jayasuriya H, Ondeyka JG, Herath KB, Zhang C, Zink DL, Tsou NN,
Ball RG, Basilio A, Genilloud O, Diez MT, Vicente F, Pelaez F, Young K, Wang
J. Isolation, structure, and absolute stereochemistry of platensimycin, a broad spec-
trum antibiotic discovered using an antisense differential sensitivity strategy. J. Am.
Chem. Soc. 2006;128:11916-11920.
164. Wang J, Soisson SM, Young K, Shoop W, Kodali S, Galgoci A, Painter R,
Parthasarathy G, Tang YS, Cummings R, Ha S, Dorso K, Motyl M, Jayasuriya
H, Ondeyka J, Herath K, Zhang C, Hernandez L, Allocco J, Basilio A, Tormo JR,
Genilloud O, Vicente F, Pelaez F, Colwell L, Lee SH, Michael B, Felcetto T, Gill C,
